DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lapaquistat
Lapaquistat
Stems for Nonproprietary Drug Names
Kevin C Maki CV 20June2019
CURRENT MEDICAL CHEMISTRY Repositioning of TAK-475 in Mevalonate Kinase Disease: Translating Theory Into Practice
A Chemical Biology Screen Identifies a Vulnerability of Neuroendocrine
Summary Results
2 12/ 35 74Al
Screening for Dyslipidemia in Younger Adults: Systematic Review to Update the 2008 U.S
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Lipid Therapeutics Update - Going Above and Beyond Statin Therapy
Kevin C Maki CV 24Aug2021
A Genomic DNA Reporter Screen Identifies Squalene Synthase Inhibitors That Act Cooperatively with Statins to Upregulate the Low-Density Lipoprotein Receptor S
New Therapeutic Developments in Lipidology
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
A Review on Anti-Cholesterol Drugs and Their Mechanisms
Summary Results
(12) Patent Application Publication (10) Pub. No.: US 2011/0077232 A1 Monopoli Et Al
Pharmaabkommen A1 E
Top View
Novel Therapies and New Targets of Treatment for Familial Hypercholesterolemia
Bioactive Compound Library Plus (96-Well)
Summary Results
'Role of Skeletal Muscle Transport Systems in Statin-Induced
Statins, Muscle Disease and Mitochondria
List of Abbreviations
(12) United States Patent (10) Patent No.: US 8,329,691 B2 Imaeda Et Al
Chapter 16 Treatment of Familial Hypercholesterolemia
WO 2008/021388 Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Wo 2011/031964 A2
Mitochondrial DNA Alterations and Statin-Induced Myopathy
Garcia-Ruiz Et Al. 1 STATINS and PROTEIN PRENYLATION IN
FUTURE TREATMENTS the Future of Treatment Options for Dyslipidemia Will Most Likely Involve the Evaluation of Other Parameters Besides LDL-C
Emerging Antidyslipidemic Drugs
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri